Rebecca Taub

Rebecca Taub" alt=" Rebecca Taub" itemprop="image">

Company: Madrigal Pharmaceuticals

Job title: Founder, Director & Chief Medical Officer, President R&D


Panel Discussion & Q&A: Using AI-Powered NASH Pathology to Accelerate NASH Drug Development: Where Are We Today & Where Are We Headed? 5:35 pm

Discussing latest advancements of AI-powered pathology to address the most immediate issues with variability in CRN scoring for enrollment and endpoints to advance NASH drug development Tackling numerous challenges that impact trial success including inter-reader variability from manual reads, trial delays due to challenging patient enrollment, and additional costs or delays due to inconsistent performance…Read more

day: Accelerating NASH Drug Development with AI-Powered NASH Pathology

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.